Innate Pharma SA (NASDAQ:IPHA)
| 2.89 Delayed Data As of Jul 01 |  +0.19 / +7.04%Today’s Change | 2.00 Today|||52-Week Range 11.95 | -36.62% Year-to-Date |
Latest IPHA News | Press Releases
No recent news for Innate Pharma SA.
Today’s Trading
| Previous close | 2.70 |
| Today’s open | 2.84 |
| Day’s range | 2.84 - 2.89 |
| Volume | 21 |
| Average volume (3 months) | 24,553 |
| Market cap | $230.5M |
Data as of 3:58pm ET, 07/01/2022
Growth & Valuation
| Earnings growth (last year) | +15.09% |
| Earnings growth (this year) | +99.14% |
| Earnings growth (next 5 years) | -22.50% |
| Revenue growth (last year) | -77.90% |
| P/E ratio | NM |
| Price/Sales | 25.34 |
| Price/Book | 1.88 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ZOMZomedica Corp | -0.01 | -5.36% |
| THTXTheratechnologies In... | -0.16 | -7.05% |
| GTHXG1 Therapeutics Inc | +0.24 | +4.86% |
| GSGTFGensight Biologics S... | 0.00 | 0.00% |
Data as of 5:58pm ET, 07/01/2022
Financials
| Next reporting date | -- |
| EPS forecast (this quarter) | -- |
| Annual revenue (last year) | $14.3M |
| Annual profit (last year) | -$62.4M |
| Net profit margin | -375.48% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters --, -- |
Forecasts
